Topic 11 -- Abstracts with Biological Entities (English) - 75 Topics / Sub-Topic Model 15 - 15 Topics

cite ad title authors publish year publish time dataset abstract mentions covid pmcid pubmed id doi cord uid topic weight Similarity scispacy Similarity specter
1 De_Clercq_2007 Status presens of antiviral drugs and strategies: Part II: RNA VIRUSES (EXCEPT RETROVIRUSES) De Clercq, Erik 2007 2007-12-31 PMC N PMC7146830 10.1016/s1075-8593(06)05002-7 v9s8xynb 0.888706 De_Clercq_2007 De_Clercq_2007, Debing_2013, Martínez_2008, De_Clercq_2007
2 De_Clercq_2007 Status Presens of Antiviral Drugs And Strategies: Part I: DNA Viruses and Retroviruses De Clercq, Erik 2007 2007-12-31 PMC N PMC7146823 10.1016/s1075-8593(06)05001-5 7ujqdujd 0.872262 De_Clercq_2007 De_Clercq_2007, De_Clercq_2007, Debing_2013, Martínez_2008
3 De_Clercq_2007 7.10 Viruses and Viral Diseases De Clercq, E. 2007 2007-12-31 PMC N PMC7151824 10.1016/b0-08-045044-x/00211-x hwpu6mko 0.790501 Paintsil_2009, Vardanyan_2016
4 Clercq_2012 Highlights in Antiviral Drug Research: Antivirals at the Horizon Clercq, Erik De 2012 2012-05-02 PMC N PMC7168470 22553111.0 10.1002/med.21256 53xret5p 0.672173 De_Clercq_2007
5 De_Clercq_2019 New Nucleoside Analogues for the Treatment of Hemorrhagic Fever Virus Infections De Clercq, Erik 2019 2019-08-07 PMC N PMC7159701 31389664.0 10.1002/asia.201900841 rmxin1da 0.650228
6 De_Clercq_2010 The next ten stories on antiviral drug discovery (part E): advents, advances, and adventures De Clercq, Erik 2010 2010-12-13 PMC N PMC7168424 19844936.0 10.1002/med.20179 dkt4cqer 0.606955
7 Kim_Y_2016 Potent inhibition of enterovirus D68 and human rhinoviruses by dipeptidyl aldehydes and α-ketoamides Kim, Yunjeong; Kankanamalage, Anushka C. Galasiti; Damalanka, Vishnu C.; Weerawarna, Pathum M.; Groutas, William C.; Chang, Kyeong-Ok 2016 2016-01-31 None N PMC4698184 26658373.0 10.1016/j.antiviral.2015.11.010 4t2y69o9 0.496260 Wu_H_2016
8 Cheng_2016 Enfuvirtide−PEG conjugate: A potent HIV fusion inhibitor with improved pharmacokinetic properties Cheng, Shuihong; Wang, Yan; Zhang, Zhenxing; Lv, Xun; Gao, George F.; Shao, Yiming; Ma, Liying; Li, Xuebing 2016 2016-10-04 PMC N PMC7115413 27240277.0 10.1016/j.ejmech.2016.05.027 jnketv7y 0.489259 Zhu_X_2015
9 Jefferson_2009 Antivirals for the common cold Jefferson, Tom 2009 2009-11-10 PMC N PMC7123222 10.1007/978-3-7643-9912-2_10 t8jzsrb7 0.486216 Peyclit_2019, Wu_H_2016
10 Ellner_1988 Management of acute and chronic respiratory tract infections Ellner, Jerrold J. 1988 1988-09-16 PMC N 3048091.0 10.1016/0002-9343(88)90456-1 i94lyfsh 0.482694 Wisskirchen_2014
11 Baltina_2010 Prospects for the creation of new antiviral drugs based on glycyrrhizic acid and its derivatives (a review) Baltina, L. A.; Kondratenko, R. M.; Baltina, L. A.; Plyasunova, O. A.; Pokrovskii, A. G.; Tolstikov, G. A. 2010 2010-02-04 PMC N PMC7089237 10.1007/s11094-010-0348-2 hr46kv03 0.458397 Liu_A_2012, Bekut_2018, Lee_C_2019
12 Anang_2018 Recent Advances Towards the Development of a Potent Antiviral Against the Hepatitis E Virus Anang, Saumya; Kaushik, Nidhi; Surjit, Milan 2018 2018-06-28 NONCOMM N PMC6160310 30271744.0 10.14218/jcth.2018.00005 hkxlq3os 0.431123 D’Alessandro_2020, Debing_2014
13 Deval_2014 Inhibition of viral RNA polymerases by nucleoside and nucleotide analogs: therapeutic applications against positive-strand RNA viruses beyond hepatitis C virus Deval, Jerome; Symons, Julian A; Beigelman, Leo 2014 2014-12-31 PMC N PMC7102778 25194816.0 10.1016/j.coviro.2014.08.004 qovrstak 0.422351 Vardanyan_2016
14 Razonable_2011 Antiviral Drugs for Viruses Other Than Human Immunodeficiency Virus Razonable, Raymund R. 2011 2011-10-31 None N PMC3184032 21964179.0 10.4065/mcp.2011.0309 hpuogyb0 0.420112 Vardanyan_2016, Paintsil_2009, Meanwell_2003
15 Kinast_2019 Hepatitis E Virus Drug Development Kinast, Volker; Burkard, Thomas L; Todt, Daniel; Steinmann, Eike 2019 2019-05-28 COMM-USE N PMC6631701 31141919.0 10.3390/v11060485 5rsk6g7l 0.401327 Jerome_2005 Debing_2014
16 Schandock_2017 Macromolecular Antiviral Agents against Zika, Ebola, SARS, and Other Pathogenic Viruses Schandock, Franziska; Riber, Camilla Frich; Röcker, Annika; Müller, Janis A.; Harms, Mirja; Gajda, Paulina; Zuwala, Kaja; Andersen, Anna H. F.; Løvschall, Kaja Borup; Tolstrup, Martin; Kreppel, Florian; Münch, Jan; Zelikin, Alexander N. 2017 2017-09-25 PMC N PMC7161897 28945945.0 10.1002/adhm.201700748 hb1inqy8 0.401257
17 Feng_2018 Addressing the selectivity and toxicity of antiviral nucleosides Feng, Joy Y 2018 2018-03-13 NONCOMM N PMC5890540 29534607.0 10.1177/2040206618758524 uajl5wyk 0.395733 Jerome_2005 Martínez_2008, Zhu_X_2015, Al‐Bari_2017
18 Berdis_2008 DNA Polymerases as Therapeutic Targets Berdis, Anthony J. 2008 2008-08-01 PMC N PMC2692436 18642851.0 10.1021/bi801179f 5rpdt3fs 0.339156
19 Blaising_2014 Arbidol as a broad-spectrum antiviral: An update Blaising, Julie; Polyak, Stephen J.; Pécheur, Eve-Isabelle 2014 2014-07-31 PMC N PMC7113885 24769245.0 10.1016/j.antiviral.2014.04.006 d9borky8 0.337571 Jerome_2005 Lee_C_2019
20 Sperber_1987 Antiviral Chemotherapyand Prophylaxis of Viral Respiratory Disease Sperber, Steven J.; Hayden, Frederick G. 1987 1987-12-31 PMC N PMC7131954 2446820.0 10.1016/s0272-2712(18)30721-2 2h6es4x4 0.328038 D’Alessandro_2020
21 Ramírez-Olivencia_2019 Use of ribavirin in viruses other than hepatitis C. A review of the evidence Ramírez-Olivencia, German; Estébanez, Miriam; Membrillo, Francisco Javier; Ybarra, Maria del Carmen 2019 2019-11-30 PMC N 10.1016/j.eimce.2018.05.018 vasphfdy 0.327639 Jerome_2005 D’Alessandro_2020
22 Debing_2014 Antiviral strategies for hepatitis E virus Debing, Yannick; Neyts, Johan 2014 2014-02-28 PMC N PMC7113752 24374149.0 10.1016/j.antiviral.2013.12.005 n0acj460 0.327028 Jerome_2005, Wisskirchen_2014
23 Meanwell_2003 Chapter 22. Non-HIV antiviral agents Meanwell, Nicholas A.; Serrano-Wu, Michael H.; Snyder, Lawrence B. 2003 2003-12-31 PMC N 10.1016/s0065-7743(03)38023-6 d4qcckh1 0.306118 Vardanyan_2016, Paintsil_2009
24 Rollinger_2010 The human rhinovirus: human‐pathological impact, mechanisms of antirhinoviral agents, and strategies for their discovery Rollinger, Judith M.; Schmidtke, Michaela 2010 2010-12-13 PMC N PMC7168442 19714577.0 10.1002/med.20176 ycc3csyh 0.300002